A real-life study of isatuximab plus pomalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: IMAGE
Latest Information Update: 25 Jan 2023
At a glance
- Drugs Dexamethasone (Primary) ; Isatuximab (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms IMAGE
Most Recent Events
- 25 Jan 2023 New trial record
- 13 Dec 2022 Results of sub-group analysis were presented at the 64th American Society of Hematology Annual Meeting and Exposition.
- 13 Dec 2022 Interim results (n=299) were presented at the 64th American Society of Hematology Annual Meeting and Exposition.